Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
--------------------------------------------------------------------
Source: CNBC
Published: 2026-08-04 21:13 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Financial Markets, Retail
--------------------------------------------------------------------
Snippet:
Pfizer on Tuesday reported second-quarter results that topped estimates and hiked the low end of its revenue outlook, citing the stronger-than-expected performance of non-Covid products.
--------------------------------------------------------------------